Compare VCEL & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VCEL | PLSE |
|---|---|---|
| Founded | 1989 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 2015 |
| Metric | VCEL | PLSE |
|---|---|---|
| Price | $35.06 | $19.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 1 |
| Target Price | ★ $57.75 | $22.00 |
| AVG Volume (30 Days) | ★ 702.1K | 224.9K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.00 | N/A |
| EPS | ★ 0.32 | N/A |
| Revenue | ★ $276,259,000.00 | N/A |
| Revenue This Year | $19.10 | $840.00 |
| Revenue Next Year | $17.95 | $287.54 |
| P/E Ratio | $110.64 | ★ N/A |
| Revenue Growth | ★ 16.45 | N/A |
| 52 Week Low | $28.95 | $12.56 |
| 52 Week High | $45.97 | $26.30 |
| Indicator | VCEL | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 58.72 | 45.72 |
| Support Level | $34.26 | $13.62 |
| Resistance Level | $38.48 | $20.40 |
| Average True Range (ATR) | 1.37 | 1.52 |
| MACD | 0.46 | -0.32 |
| Stochastic Oscillator | 94.67 | 29.27 |
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.